Delivery Order SPE2DB22D3004-SPE2DB25FPJ14

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,068.03 firm fixed-price delivery order is for the supply of PROGESTERONE 100 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award, valued at $11,730.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567254709 - PROGESTERONE 100 MG CAPSULE 100S, with a completion date of February 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,195.73, is for the delivery of 4567222881 ! PROGESTERONE 200 MG CAPSULE 30S. It is a firm fixed-price delivery order contract with a period of performance through February 11, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $13,415.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567300692 PROGESTERONE 200 MG CAPSULE 100S, with an ultimate completion date of February 19, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $9,415.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROGESTERONE 200 MG CAPSULE 100S medical supplies, with a completion date of February 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,459.46 Firm Fixed Price Delivery Order is for the supply of 4567395183 - Progesterone 200 mg Capsule 100s. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with ID SPE2DB24D1006|SPE2DB25FCEDY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,305.66 firm fixed-price delivery order is for the supply of 4567074495 - Progesterone 200 mg Capsule 100s. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,287.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of PROGESTERONE 100 MG CAPSULE 30S, with an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award (SPE2DB20D1004|SPE2DB25FNFBQ) from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567341588 ! PROGESTERONE 100 MG CAPSULE 100S, with a ceiling value of $1,154.08 and a completion date of February 24, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,498.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566964990 - Progesterone 200 MG Capsule 100S to support military and federal healthcare programs. The award has an ultimate completion date of January 17, 2025 and is structured as a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPJ14
    Delivery Order

This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPJ14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,172.54 firm fixed-price delivery order is for the supply of 4567117594 ! PROGESTERONE 200 MG CAPSULE 100S, with a period of performance through February 3, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition. The contract supports critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/2/25, 10:05 AM